Literature DB >> 29631449

Dyadic resources in the return to work of cancer survivors: exploring supervisor-employee perspectives.

Dana Yagil1, Hadass Goldblatt2, Miri Cohen3.   

Abstract

Purpose: The number of working-age people recovering from cancer is gradually on the rise; yet, cancer survivors have higher rates of unemployment compared to other employees. Cancer survivors returning to work cope with symptoms of fatigue, distress, cognitive difficulties and physical limitations. The present article addresses the supervisor-cancer survivor dyad as the unit of analysis, in an attempt to identify the dyadic resources that underlie the coping of the supervisor-employee unit with return to work. Materials and methods: In-depth, semi-structured individual interviews were conducted with 12 dyads of cancer survivors and their supervisors, representing successful return to work, followed by comparative content analysis of the data.
Results: Four themes were revealed: (1) Congruent supervisor-cancer survivor views regarding personalized/standard management of cancer survivors' returning to work; (2) Return to work as a team work approach; (3) Commitment and persistence in the face of obstacles, and (4) Supervisor and cancer survivor mutual appreciation. Conclusions: Joint coping of supervisors and cancer survivors with the difficulties of the return to work process is perceived to contribute significantly to the success of return to work. Training of cancer survivors and supervisors conducted by rehabilitation professionals regarding aspects of the orientation toward return to work is suggested. Implication for rehabilitation Cancer survivors have different preferences regarding standard versus exceptional organizational treatment following return to work. Organizational acknowledgment of the cancer survivor's value for the organizations supports cancer survivors' return to work. Cancer survivors can benefit from a sense of responsibility and involvement in decision making regarding the process of return to work.

Entities:  

Keywords:  Cancer survivors; qualitative research; return to work; supervisors; working-age

Mesh:

Year:  2018        PMID: 29631449     DOI: 10.1080/09638288.2018.1459885

Source DB:  PubMed          Journal:  Disabil Rehabil        ISSN: 0963-8288            Impact factor:   3.033


  6 in total

1.  Factors influencing return to work of cancer survivors: a population-based study in Italy.

Authors:  Sara Paltrinieri; Massimo Vicentini; Elisa Mazzini; Elena Ricchi; Stefania Fugazzaro; Pamela Mancuso; Paolo Giorgi Rossi; Stefania Costi
Journal:  Support Care Cancer       Date:  2019-05-25       Impact factor: 3.603

2.  Understanding Cancer Survivors' Needs and Experiences Returning to Work Post-Treatment: A Longitudinal Qualitative Study.

Authors:  Robin Urquhart; Sarah Scruton; Cynthia Kendell
Journal:  Curr Oncol       Date:  2022-04-23       Impact factor: 3.109

3.  Colorectal Cancer and Return to Work: A Pilot Study of Recruiting Cancer Survivors and Their Employers.

Authors:  Inga Gruß; Cathy J Bradley; Matthew P Banegas
Journal:  Perm J       Date:  2021-05

4.  'Beyond Cancer': a study protocol of a multimodal occupational rehabilitation programme to support breast cancer survivors to return work.

Authors:  Dianne Melinda Sheppard; Dorothy Frost; Michael Jefford; Moira O'Connor; Georgia Halkett
Journal:  BMJ Open       Date:  2019-12-15       Impact factor: 2.692

5.  Identification of actions to be taken by managers to facilitate the return to work of cancer survivors: Consensus between managers and cancer survivors.

Authors:  B Porro; S J Tamminga; A G E M de Boer; A Petit; Y Roquelaure; M A Greidanus
Journal:  BMC Public Health       Date:  2022-10-12       Impact factor: 4.135

6.  Long-term employment status and quality of life after cancer: A longitudinal prospective cohort study from diagnosis up to and including 5 years post diagnosis.

Authors:  Sietske J Tamminga; Lyanne P Jansen; Monique H W Frings-Dresen; Angela G E M de Boer
Journal:  Work       Date:  2020
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.